Keyphrases
Pulmonary Hypertension
100%
Vasodilator
100%
Sheep
100%
Pulmonary Artery Pressure
100%
Vasodilator Therapy
100%
Nitroglycerin
50%
Sodium Nitroprusside
50%
Cardiac Output
50%
Pulmonary Vascular Resistance
50%
Hydralazine
50%
Prostaglandin E1 (PGE1)
50%
Clinical Application
25%
Heart Rate
25%
Heart Rhythm
25%
Continuous Infusion
25%
Arterial Pressure
25%
Systemic Effects
25%
Systemic Vascular Resistance
25%
Hemodynamic Profile
25%
Endoperoxide
25%
Thromboxane A2 (TXA2)
25%
Systemic Blood Pressure
25%
U46619
25%
Equivalent Reduction
25%
Pressure Output
25%
Rational Selection
25%
Pulmonary Vasodilators
25%
Pulmonary Effects
25%
Systemic Arteries
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hydralazine
100%
Vasodilator Agent
100%
Glyceryl Trinitrate
100%
Nitroprusside Sodium
100%
Pulmonary Hypertension
100%
Prostaglandin E1
100%
Endoperoxide
50%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
50%
Peripheral Vasodilating Agent
50%
Thromboxane A2
50%